AIFA refutes claims HyalRoute stake deal is “fabricated”
All In FutureTech
All In FutureTech AIFA | 0.00 |
- All In FutureTech Alliance issued a formal rebuttal to claims that its May 22, 2026 HyalRoute controlling-stake acquisition announcement was “false” or “fabricated.”
- The equity deal was negotiated and signed with registered HyalRoute shareholders, not management; it does not cover board or management changes.
- Closing remains conditional on approvals and other conditions; the group is exploring a tender offer that could lift support above 70%.
- Transaction terms cited include a price of USD 10 per share, implying a USD 4 billion valuation for HyalRoute.
- AIFA reserved the right to pursue legal action over statements it views as misleading.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. All in FutureTech Alliance Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606081029PRIMZONEFULLFEED9733325) on June 08, 2026, and is solely responsible for the information contained therein.
